Clinical Use of Otic Solution Ear Drop

Main Article Content

Chayada Chanasriyotin
Visan Mahasitthiwat

Abstract

Ear drops contain drugs and a solvent. Ear drops include five categories: 1) Cerumenolytic: earwax softener to help soften earwax and make it slips out easily with the use of water and a detergent. 2) Anti-bacterial agents: common pathogenic bacteria are Pseudomonas aeruginosa and Staphylococci. Ciprofloxacin has been recognized as standard non-ototoxic therapy for infections in the middle and inner ear. 3) Anti-fungal agents: the most common fungal pathogens are Aspergillus nigra and Aspergillus fumigatus. Commonly-used anti-fungal include clotrimazole, acetic acid, gentian violet and boric acid. 4) Corticosteroid: the drugs is commonly used to reduce pain and swelling. 5.) Anesthetic: Knowing how to administer medication and the common complications that may occur is important for the safety of patients.

Article Details

How to Cite
Chanasriyotin, C., & Mahasitthiwat, V. (2017). Clinical Use of Otic Solution Ear Drop. Vajira Medical Journal : Journal of Urban Medicine, 61(3), 225–234. Retrieved from https://he02.tci-thaijo.org/index.php/VMED/article/view/196259
Section
Review Articles

References

1. Morizono T, Paparella MM, Juhn SK. Ototoxicity of propylene glycol in experimental animal. Am J Otolaryngol. 1980; 1: 393-9.

2. Mj B, Doree C, Burton MJ, Doree C. Ear drops for the removal of ear wax. Cochrane Database Syst Rev. 2009;(1):1–3.

3. Roland PS, Smith TL, Schwartz SR, Rosenfeld RM, Ballachanda B, Earll JM, et al. Clinical practice guideline: Cerumen Impaction. Otolaryngol Head Neck Surg. 2008;139 (3 Suppl 2):S1-21.

4. Kim JK, Cho JH. Change of external auditory canal pH in acute otitis externa. Ann Otol Rhinol Laryngol. 2009;118(11): 769–72.

5. Rosenfeld RM, Schwartz SR, Cannon CR, Roland PS, Simon GR, Kumar KA, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014;150(1 Suppl):S1–24.

6. Tsilis NS, Vlastarakos P V, Chalkiadakis VF, Kotzampasakis DS, Nikolopoulos TP. Chronic otitis media in children: an evidence-based guide for diagnosis and management. Clin Pediatr (Phila). 2013;52(9):795–802.

7. Dohar J, Kenna M, Wadowsky R. In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics. Am J Otolaryngol. 1996;17:207–9.

8. Brummett RE, Harris RF, Lindgren JA. Detection of ototoxicity from drugs applied topically to the middle ear space. Laryngoscope. 1976;86:1177-87.

9. Greg M, Leonard R, Ototoxicity of ototopical antibiotic drops in humans. Otolaryngol Head Neck Surg. 2004;130: S79-82.

10. Kaplan DM, Hehar SS, Bance ML, Rutka JA. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere’s disease: further evidence for topical eardrop ototoxicity. Laryngoscope. 2002;112: 689-95.

11. Wright C, Meyerhoff W. Ototoxicity of otic drops applied to the middle ear in the chinchilla. Am J Otolaryngol. 1984;5: 166–76.

12. Munguia R, Daniel SJ. Ototopical antifungal and otomycosis: A review. Int J Pediatr Otorhinolaryngol. 2008;72: 453-9.

13. Fairbanks DNF. Pocket guide to antimicrobial therapy in otolaryngology – head and neck surgery, 13th Ed. Alexandria, VA: American Academy of Otolaryngology Head and Neck Surgery Foundation; 2005. p 55-7.

14. Thailand National List of Essential Medicines (NLEM) 2016. 2nd Revision. Nonthaburi: Ministry of Public Health; 2016. p 84-6.

15. Phillips JS, Yung MW, Burton MJ, Swan IRC. Evidence review and ENT-UK consensus report for the use of aminoglycoside-containing ear drops in the presence of an open middle ear. Clin Otolaryngol. 2007;32(5): 330–6.